Dexterra Group Inc.
HZNOF
$5.60
$0.081.45%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 731.92M | 724.87M | 725.29M | 699.77M | 687.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 731.92M | 724.87M | 725.29M | 699.77M | 687.68M |
| Cost of Revenue | 615.35M | 612.04M | 612.00M | 592.41M | 583.10M |
| Gross Profit | 116.57M | 112.83M | 113.29M | 107.36M | 104.58M |
| SG&A Expenses | 40.84M | 38.05M | 34.93M | 32.64M | 32.18M |
| Depreciation & Amortization | 25.68M | 25.19M | 25.93M | 26.06M | 25.93M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 681.87M | 675.28M | 672.85M | 651.10M | 641.21M |
| Operating Income | 50.05M | 49.59M | 52.44M | 48.67M | 46.47M |
| Income Before Tax | 39.09M | 37.75M | 38.73M | 35.42M | 35.25M |
| Income Tax Expenses | 11.70M | 9.68M | 10.09M | 9.02M | 8.68M |
| Earnings from Continuing Operations | 27.39 | 28.07 | 28.64 | 26.40 | 26.57 |
| Earnings from Discontinued Operations | -12.84M | -18.68M | -14.52M | -12.60M | -6.66M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -162.30K | -121.10K | -119.60K | -73.40K | -97.00K |
| Net Income | 14.39M | 9.27M | 13.99M | 13.73M | 19.81M |
| EBIT | 50.05M | 49.59M | 52.44M | 48.67M | 46.47M |
| EBITDA | 75.73M | 74.78M | 78.37M | 74.73M | 72.39M |
| EPS Basic | 0.23 | 0.14 | 0.22 | 0.21 | 0.30 |
| Normalized Basic EPS | 0.39 | 0.38 | 0.41 | 0.38 | 0.36 |
| EPS Diluted | 0.23 | 0.14 | 0.21 | 0.21 | 0.30 |
| Normalized Diluted EPS | 0.39 | 0.38 | 0.41 | 0.38 | 0.36 |
| Average Basic Shares Outstanding | 256.07M | 256.97M | 257.91M | 259.00M | 259.97M |
| Average Diluted Shares Outstanding | 257.22M | 257.71M | 258.60M | 259.70M | 260.67M |
| Dividend Per Share | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
| Payout Ratio | 113.90% | 178.63% | 119.31% | 122.70% | 85.22% |